Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05685433 · ClinicalTrials.gov registry record · NA

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

A NA study of Overactive Bladder and Urge Incontinence, sponsored by Valencia Technologies Corporation.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
20
Study locations

NCT05685433 is a NA study of Overactive Bladder and Urge Incontinence that is actively recruiting participants, run by Valencia Technologies Corporation. The registered enrollment target is 200 participants, roughly in line with the 207-participant average among 45 other Overactive Bladder trials with a reported enrollment target. The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05685433, a NA study of Overactive Bladder and Urge Incontinence, is actively recruiting participants, sponsored by Valencia Technologies Corporation.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
20
Study locations

Study Summary

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

Interventions

  • DEVICE eCoin Tibial Nerve Stimulation

Study Locations (20)

California

  • University of California, Irvine - Irvine
  • AIR Research - Los Angeles
  • Stanford Health - Stanford

Alabama

  • Urology Centers of Alabama - Homewood
  • USA Health - Mobile

Iowa

  • The Iowa Clinic - Ankeny
  • University of Iowa - Iowa City

Kansas

  • University of Kansas Medical Center Research Institute, Inc - Kansas City
  • Cypress Medical Research - Wichita

Arkansas

  • Arkansas Urology - Little Rock

Florida

  • Urological Research Network Corp - Hialeah

Georgia

  • The Emory Clinic - Atlanta

Illinois

  • Rush University - Chicago

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-01-26
Est. Completion 2031-12
Phase NA

What the Registry Record Tells You About NCT05685433

The ClinicalTrials.gov registry entry for NCT05685433 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 207-participant average among 45 other Overactive Bladder trials with a reported enrollment target. The listed sponsor is Valencia Technologies Corporation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which eCoin Tibial Nerve Stimulation is the first listed.

NCT05685433 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Alabama, Iowa.

Frequently Asked Questions

What is clinical trial NCT05685433 about?

NCT05685433 is a clinical study titled "A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)". A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

What is the current status of trial NCT05685433?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-01-26. Estimated completion is 2031-12.

What conditions does trial NCT05685433 study?

This clinical trial studies the following conditions: Overactive Bladder, Urge Incontinence, Urinary Urge Incontinence, Incontinence, Urinary.

What interventions are being tested in trial NCT05685433?

The interventions under investigation include: eCoin Tibial Nerve Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05685433?

This trial is sponsored by Valencia Technologies Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05685433 being conducted?

This trial has 20 study locations across Alabama, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.